People

Markus Hosang
Markus Hosang joined BioMedPartners in 2004 following venture investing at MPM Capital and approximately two decades of pharmaceutical research leadership at Roche. He studied biochemistry at ETH Zurich and undertook postgraduate training at Stanford and the University of Washington. These are institutional manager affiliations; no personal portfolio investment is inferred.
Roles
BioMedPartners
CurrentManaging Partner
BioMedPartners
CurrentVice-Chair, statutory board (2021 official appointment confirmation)